Fact CheckerSign in

NCT07380802Completed

Petit Cactus Study

Petit Cactus: A Carbohydrate Counting Mobile Application for Canadians With Type 1 Diabetes - A Proof-of-Concept Study

Source: ClinicalTrials.gov · Last updated 2 Feb 2026

Brief summary (registry, in English)

The goal of this trial is to test a newly developed carbohydrate counting mobile application (named Petit Cactus) with photo recognition, for people with type 1 diabetes. To evaluate Petit Cactus, our objectives are: 1. To measure the association between app engagement and changes in blood glucose management over the same period. 2. To assess the usability of the app, focusing on engagement (i.e., frequency of meal logs) over 3 months and user satisfaction. 3. To validate the nutritional data obtained from the app's photo recognition algorithm by comparing it with a validated nutrient intake method (in this case, a web-based 24h recall). Participants will submit their Ambulatory Glucose Profile (i.e., CGM data) at the beginning and at the end of 3 months, download the app to use for carbohydrate counting for the 3-month duration, complete a usability questionnaire at the end of 3 months, and complete an end-of-study interview to report on their satisfaction with the app.

Status (registry)
Completed
Study type
Interventional
Enrollment
73 (actual)
First submitted
22 Sept 2025
Start date
Feb 2025
Primary completion date
Aug 2025
Lead sponsor
McGill University
NCT number
NCT07380802

What you commit to

  • Study type: Interventional
  • Participants enrolled: 73
  • From Feb 2025 to the primary completion date, Aug 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • \- Unable to use a smartphone with internet access

Who the study is looking for

  • Diagnosed with T1D for at least 1 year on basal-bolus insulin regimen
  • Uses a Continuous Glucose Monitoring (CGM) system
  • Aged 14 years or older; 4. Residing in Canada
  • Able to speak/understand French or English
  • Uses carbohydrate counting as part of treatment regimen i.e., knows their insulin-to-carb ratio and correction factors.

Age in the registry: 14 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
McGill University
Coordinator of this site? Confirm its status
MontrealCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.